thanks AB, nothing new but always good to get a reminder of the positives during periods of ongoing delays.
honestly not sure what to make of the announcement today that the Phase III results will be delayed by a few more weeks. Not sure how to read the reason for delay, was SPL sloppy / unprepared or was the FDA being typically bureaucratic. In the end, nothing has really changed - we keep waiting - and SPL continues to progress licensing deals and discussions with the FDA. Results remain blinded / unknown so we can continue to speculate for a few more weeks.
We may even end up with Dep Dox results before phase III BV prevention.
Starpharma is one of Bell Potter top picks for FY18, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |